Which are the causes of Primary Hyperoxaluria?

Primary Hyperoxaluria is a rare, life-threatening metabolic disorder caused by a genetic deficiency in liver enzymes, which leads to the overproduction of oxalate. This excess oxalate cannot be processed by the kidneys, resulting in recurrent kidney stones, nephrocalcinosis, and potentially systemic organ damage. Because it is an inherited condition, the primary cause is a mutation in specific genes rather than external environmental triggers.

What causes Primary Hyperoxaluria?

The fundamental cause of Primary Hyperoxaluria is a dysfunction in the glyoxylate metabolism pathway within the liver. In a healthy body, specific enzymes break down glyoxylate. In individuals with Primary Hyperoxaluria, these enzymes are either missing or malfunctioning, forcing the liver to convert excess glyoxylate into oxalate. Think of it like a clogged drain in a sink; because the "drain" (the enzyme pathway) is blocked, the "water" (oxalate) overflows, causing severe damage to the kidneys and other tissues.

Is Primary Hyperoxaluria hereditary?

Yes, Primary Hyperoxaluria is an autosomal recessive genetic disorder. This means that for a child to develop the condition, they must inherit two mutated copies of a specific gene—one from each parent. Parents who are carriers of these mutations typically do not show symptoms themselves. The specific genes associated with the three known types of Primary Hyperoxaluria include:

• Type 1 (PH1): Mutations in the AGXT gene (responsible for approximately 70-80% of cases).


• Type 2 (PH2): Mutations in the GRHPR gene.


• Type 3 (PH3): Mutations in the HOGA1 gene.

Are there environmental triggers for this condition?

Unlike some kidney stone conditions caused by diet, Primary Hyperoxaluria is not caused by lifestyle or environmental factors. However, environmental triggers—such as dehydration or high intake of oxalate-rich foods—can act as risk factors that worsen the clinical progression. While these factors do not cause the disease, they may accelerate the rate at which kidney stones form or crystal deposits accumulate in the body.

What is the current state of research?

Researchers are actively studying the etiology of Primary Hyperoxaluria, with a major focus on gene therapy and RNA interference (RNAi) treatments. These approaches aim to "silence" the production of the problematic enzymes at the genetic level, preventing the overproduction of oxalate at its source rather than just managing the resulting kidney damage.

Next steps

• Consult a metabolic specialist or nephrologist to confirm your genetic profile.


• Undergo genetic testing to identify the specific mutation type.


• Connect with the 2 community members on DiseaseMaps.org to share insights and support.


• Monitor the NIH GARD website for updates on emerging RNAi-based clinical trials.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Primary Hyperoxaluria.


• Orphanet: Primary Hyperoxaluria portal.


• OMIM (Online Mendelian Inheritance in Man): Entry for Primary Hyperoxaluria.


• Oxalosis & Hyperoxaluria Foundation (OHF).